Nanomedicine as a Path to Counteract Infectious Disease
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 45
Special Issue Editor
Interests: nanomaterials; nanoparticles; antibacterial and antimicrobial drugs; antibiotic-free strategies; gut microbiota; biofilms; infectious diseases; targeted nano-bio approaches
Special Issue Information
Dear Colleagues,
As Guest Editor of this Special Issue of Life, I would like to invite researchers to submit original and high-quality publications covering their current and novel research activities related to nanomedicine and nanoscience in the life and health sciences applied to infectious diseases.
Infectious diseases have become one of the world’s most urgent health issues. The discovery of antibiotics in the early 20th century has revolutionized the treatment of infectious diseases, saving millions of lives. However, in recent decades, the development of antibiotic resistance has become more pronounced due to the emergence of multidrug-resistant bacteria in both community- and hospital-acquired infections, animals, and the environment, resulting in increased morbidity, mortality, and economic costs. Thus, there is an urgent need for the development of novel drugs or nano approaches to prevent and/or eradicate the spread of microbial-resistant infections.
Nanomedicine, nanoscience, and nanobiotechnology have played an important role in the development of novel solutions with the discovery of new formulations to counteract infectious diseases. This Special Issue aims to cover different aspects of recent advances in the bioavailability and biodistribution of nanomedicines; delivery of improved therapeutics; innovative biomaterials; and interactions of nanomaterials with microorganisms with a focus on infectious diseases.
Researchers are invited to submit original research or review articles to this important and exciting research field.
Dr. Catarina Leal Seabra
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infectious diseases
- nanomedicine
- nanotechnology
- nanoparticles
- biomaterials
- microbiota
- biofilm treatment and/or eradication
- antimicrobial activity
- novel antimicrobial drugs
